![Harry Råstedt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Harry Råstedt is currently working as a Director at Abera Bioscience AB since 2024.
Previously, he worked as the Head-Vaccines at GlaxoSmithKline AB and as the Vice President & General Manager at GSK Vaccines GmbH.
Harry Råstedt active positions
| Companies | Position | Start |
|---|---|---|
| ABERA BIOSCIENCE AB | Director/Board Member | 12/06/2024 |
Former positions of Harry Råstedt
| Companies | Position | End |
|---|---|---|
GlaxoSmithkline AB
 GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
GSK Vaccines GmbH
 GSK Vaccines GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
GlaxoSmithkline AB
GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GSK Vaccines GmbH
GSK Vaccines GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Abera Bioscience AB
 Abera Bioscience AB BiotechnologyHealth Technology Operates as biotechnology company that develops bacterial-based platforms for delivery of vaccines and drugs | Health Technology |
- Stock Market
- Insiders
- Harry Råstedt
